Search for: "US Industries, Inc. v. PROCTER & GAMBLE COMPANY" Results 21 - 32 of 32
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Aug 2008, 1:23 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
7 Nov 2008, 3:57 am
Political flurries and potential trade mark wars (Afro-IP) House arrest for DVD pirate (Afro-IP)   Spain Government to publish ‘Manual of Best Practices in the Prosecution of Infringing Activities’ (Class 46)   Ukraine Trade marks database to be accessible free of charge (Class 46)   United Arab Emirates Limitations on trademark protection (International Law Office)   United Kingdom Financing creative businesses (IP finance) UK patent… [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate… [read post]
2 Sep 2010, 8:35 am by Stefanie Levine
  That has begun to change in recent years, as more and more foreign companies have started to use reexamination. [read post]
19 Jan 2012, 3:17 am by McNabb Associates, P.C.
Rajat Gupta, a former chief of the consulting firm McKinsey & Co and director of both Goldman Sachs Group Inc and Procter & Gamble Co, has been charged with providing illegal tips to Rajaratnam. [read post]
26 May 2015, 7:42 am
  SJS/TEN is somewhat analogous in our sandbox to mesothelioma in asbestos cases, since plaintiffs often work backwards from the diagnosis to look for some drug company to sue. [read post]
23 Dec 2023, 7:16 pm by admin
Judge Weinstein observed that when the hand waving stopped, “[t]here is no evidence that plaintiffs were exposed to the far higher concentrations involved in both animal and industrial exposure studies. [read post]
4 Dec 2013, 11:04 am by Rebecca Tushnet
  Colliersmagazine published expose about patent medicine industry, including advertising practices. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma… [read post]